Ingestible devices have been researched since the 1950s, and proof-of-concept trials support their ability to measure pH, temperature, and gastrointestinal motility. Giovanni Traverso, MB, BChir, PhD, and colleagues have developed a vitamin-sized pill that measures respiratory rate and heart rate.

Brigham researchers presented the results of a study that aimed to stratify the risks of bariatric surgery at the American College of Surgeons’ Clinical Congress 2023. Ali Tavakkoli, MD, who led the study, explains the risk profile of bariatric procedures is changing as surgeons operate on heavier and heavier patients.

Boston area experts recently commented on the digital technologies they’re using in a pilot of a surgical home hospital in bariatric surgery at Brigham and Women’s Hospital.

Researchers at Brigham and Women’s Hospital recently published data from an open-label phase 1b/2a trial suggesting induction therapy with low-dose IL-2 is safe for patients with ulcerative colitis and suppresses the disease.

In a retrospective real-world study, Brigham and Women’s Hospital researchers demonstrated that tofacitinib and ustekinumab are equally effective for achieving steroid-free clinical remission of ulcerative colitis at 12 and 52 weeks.

Researchers at Brigham and Women’s Hospital, MIT, and California Institute of Technology have devised a system for localizing and tracking wireless microdevices inside the GI tract in real-time and in non-clinical settings, with millimeter-scale spatial resolution and no need for X-ray radiation.